Status:
COMPLETED
Voice Therapy for Teachers With Voice Problems
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Phonotrauma
Eligibility:
All Genders
21+ years
Phase:
PHASE3
Brief Summary
The study compares two different forms of voice therapy, Lessac-Madsen Resonant Voice Therapy and Casper-Based Confidential Flow Therapy. The target population are teachers because they have the highe...
Eligibility Criteria
Inclusion
- Full or part time teacher including college professor, daycare and preschool
- 21 years of age and older
- Complaints of voice problems declared to be lasting continuously for one month or more
- Any structural or functional change to the larynx that appears related to phonation,including bilateral or unilateral lesions (assuming normal overlying epithelium based on clinical examination), non-specific edema, or erythema that appear by clinical history related to phonation, or primary muscle tension dysphonia or other condition related to phonation without lesions
- No concurrent ear, nose and/or throat diagnoses, e.g. acute allergies, except for chronic allergies, sinusitis, and laryngopharyngeal reflux disease (LPR)
- No vocal fold hemorrhage
- No known degenerative medical conditions (e.g., degenerative neuromuscular disease, malignant process undergoing treatment or with less than 5 years remission, uncontrolled systemic disease (e.g., auto immune disease, or hormonal condition)
- Normal hearing to 30 dB at 1000Hz - 3000Hz in the better ear
- The participant is able to start therapy within 6 weeks of the initial evaluation and can be scheduled for 8 sessions (two per visit) in a 6-week time period
- Agreement by the participant to provide information regarding days missed from work during the previous year and the year following treatment
Exclusion
- Known degenerative medical condition
- Concurrent ear-nose-throat diagnosis, e.g., acute allergies (but chronic allergies, sinusitis, and laryngopharyngeal reflux disease (LPR) are not exclusion criteria) and vocal fold hemorrhage
- Degenerative medical conditions that would exclude a participant from participation include, but are not limited to: degenerative neuromuscular disease, malignant process undergoing treatment or with less than 5 years remission, uncontrolled systemic disease (e.g. auto immune disease), or hormonal condition.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT00222937
Start Date
October 1 2005
End Date
August 1 2010
Last Update
January 25 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts Eye & Ear Infirmary, Voice and Speech Laboratory
Boston, Massachusetts, United States, 02114
2
University of Pittsburgh Medical Center, Voice Center
Pittsburgh, Pennsylvania, United States, 15219